Suppr超能文献

锌甘氨酰组氨酸金属有机配位聚合物作为一种具有体外货架稳定性的强效广谱流感疫苗平台。

Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability.

机构信息

Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill 27599, North Carolina, United States.

Florida Research and Innovation Center, Port Saint, Cleveland Clinic Florida, Port St. Lucie 33331-3609, Florida, United States.

出版信息

Mol Pharm. 2023 Sep 4;20(9):4687-4697. doi: 10.1021/acs.molpharmaceut.3c00424. Epub 2023 Aug 21.

Abstract

Current seasonal influenza vaccines are limited in that they need to be reformulated every year in order to account for the constant mutation of the virus. Hemagglutinin (HA) immunogens have been developed using a computationally optimized broadly reactive antigen (COBRA) methodology, which are able to elicit an antibody response that neutralizes antigenically distinct influenza strains; however, subunit proteins are not immunogenic enough on their own to generate a substantial immune response. Due to this, different delivery strategies and adjuvants can be used to improve immunogenicity. Recently, we reported a new coordination polymer composed of the dipeptide carnosine and zinc (ZnCar) that is able to deliver protein antigens along with CpG to generate a potent immune response. In the present work, ZnCar was used to deliver the COBRA HA immunogen Y2 and the adjuvant CpG. We incorporated Y2 into ZnCar using two different methods to assess which would be the most immunogenic. Mice vaccinated with Y2 and CpG complexed with ZnCar showed an improved humoral and cellular response when compared to mice vaccinated with soluble Y2 and CpG. Further, we demonstrate in vitro that when Y2 and CpG are coordinated with ZnCar, they are protected from degradation at 40 °C for 3 months or 24 °C for 6 months. Overall, ZnCar shows promise as a delivery vehicle for subunit vaccines, given its superior immunogenicity and in vitro storage stability.

摘要

当前的季节性流感疫苗存在局限性,因为它们需要每年重新配方,以应对病毒的不断突变。血凝素 (HA) 免疫原是使用计算优化的广泛反应性抗原 (COBRA) 方法开发的,该方法能够引发中和抗原不同的流感株的抗体反应;然而,亚单位蛋白本身的免疫原性不足以产生大量的免疫反应。因此,可以使用不同的递送策略和佐剂来提高免疫原性。最近,我们报道了一种由二肽肌肽和锌 (ZnCar) 组成的新型配位聚合物,它能够递送蛋白抗原和 CpG 以产生强烈的免疫反应。在本工作中,我们使用 ZnCar 递送电泳 COBRA HA 免疫原 Y2 和佐剂 CpG。我们使用两种不同的方法将 Y2 掺入 ZnCar 中,以评估哪种方法最具免疫原性。与接种可溶性 Y2 和 CpG 的小鼠相比,用 Y2 和 CpG 与 ZnCar 复合的小鼠表现出更好的体液和细胞反应。此外,我们在体外证明,当 Y2 和 CpG 与 ZnCar 配位时,它们在 40°C 下可保存 3 个月或在 24°C 下保存 6 个月而不会降解。总的来说,由于 ZnCar 具有优越的免疫原性和体外储存稳定性,因此有望成为亚单位疫苗的递送载体。

相似文献

1
Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability.
Mol Pharm. 2023 Sep 4;20(9):4687-4697. doi: 10.1021/acs.molpharmaceut.3c00424. Epub 2023 Aug 21.
2
Metal-Organic Coordination Polymer for Delivery of a Subunit Broadly Acting Influenza Vaccine.
ACS Appl Mater Interfaces. 2022 Jun 29;14(25):28548-28558. doi: 10.1021/acsami.2c04671. Epub 2022 Jun 15.
3
Enhancement of subunit vaccine delivery with zinc-carnosine coordination polymer through the addition of mannan.
Int J Pharm. 2024 May 10;656:124076. doi: 10.1016/j.ijpharm.2024.124076. Epub 2024 Apr 1.
5

引用本文的文献

1
2
Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates.
J Control Release. 2025 Aug 10;384:113936. doi: 10.1016/j.jconrel.2025.113936. Epub 2025 Jun 6.
3
The potential of nano- and microparticle-based influenza vaccines with enhanced shelf lives.
Nanomedicine (Lond). 2024;19(26):2135-2138. doi: 10.1080/17435889.2024.2392484. Epub 2024 Oct 8.
4
Enhancement of subunit vaccine delivery with zinc-carnosine coordination polymer through the addition of mannan.
Int J Pharm. 2024 May 10;656:124076. doi: 10.1016/j.ijpharm.2024.124076. Epub 2024 Apr 1.
5
Clinical and Preclinical Methods of Heat-Stabilization of Human Vaccines.
Mol Pharm. 2024 Mar 4;21(3):1015-1026. doi: 10.1021/acs.molpharmaceut.3c00844. Epub 2024 Jan 30.

本文引用的文献

2
Metal-organic coordination polymers for delivery of immunomodulatory agents, and infectious disease and cancer vaccines.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 Jul-Aug;15(4):e1877. doi: 10.1002/wnan.1877. Epub 2023 Jan 11.
3
Vaccine Response in the Immunocompromised Patient with Focus on Cellular Immunity.
Vaccines (Basel). 2022 May 31;10(6):882. doi: 10.3390/vaccines10060882.
4
Metal-Organic Coordination Polymer for Delivery of a Subunit Broadly Acting Influenza Vaccine.
ACS Appl Mater Interfaces. 2022 Jun 29;14(25):28548-28558. doi: 10.1021/acsami.2c04671. Epub 2022 Jun 15.
5
The Pre-Existing Human Antibody Repertoire to Computationally Optimized Influenza H1 Hemagglutinin Vaccines.
J Immunol. 2022 Jul 1;209(1):5-15. doi: 10.4049/jimmunol.2101171. Epub 2022 Jun 13.
7
Induction of broadly reactive influenza antibodies increases susceptibility to autoimmunity.
Cell Rep. 2022 Mar 8;38(10):110482. doi: 10.1016/j.celrep.2022.110482.
8
Cellular Immune Response after Vaccination in Patients with Cancer-Review on Past and Present Experiences.
Vaccines (Basel). 2022 Jan 25;10(2):182. doi: 10.3390/vaccines10020182.
9
Biomimetic metal-organic frameworks as protective scaffolds for live-virus encapsulation and vaccine stabilization.
Acta Biomater. 2022 Apr 1;142:320-331. doi: 10.1016/j.actbio.2022.02.002. Epub 2022 Feb 5.
10
The economic burden of influenza among adults aged 18 to 64: A systematic literature review.
Influenza Other Respir Viruses. 2022 May;16(3):376-385. doi: 10.1111/irv.12963. Epub 2022 Feb 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验